Stock listing
AMV Stock Price, News, Filings & Events — American Vietnamese Biotech, Inc.
Selected listing: AMV · HNX · VND · VN
This page tracks American Vietnamese Biotech, Inc.'s AMV:HNX listing on HNX in VND for VN, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AMV:HNX. AMV:HNX is the stock-level entry point for investors researching American Vietnamese Biotech, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. American Vietnamese Biotech, Inc. (AMV) is a public company operating in the biotech sector in Vietnam. With a market capitalization of approximately $5.98 million, the company focuses on developing innovative biotechnological solutions. AMV aims to contribute to advancements in the healthcare industry within its market.

- Ticker
- AMV:HNX
- Asset type
- Stock
- Market cap
- $6.0M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- HNX
- Currency
- VND
American Vietnamese Biotech, Inc. AMV:HNX stock context
This page tracks American Vietnamese Biotech, Inc.'s AMV:HNX listing on HNX in VND for VN, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AMV:HNX. AMV:HNX is the stock-level entry point for investors researching American Vietnamese Biotech, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. American Vietnamese Biotech, Inc. (AMV) is a public company operating in the biotech sector in Vietnam. With a market capitalization of approximately $5.98 million, the company focuses on developing innovative biotechnological solutions. AMV aims to contribute to advancements in the healthcare industry within its market.
Latest news from American Vietnamese Biotech, Inc.
Decision on stock under continued supervision and Notice on stock status
May 25, 2026
Decision on stock under alert, Decision on stock under continued supervision and Notice on stock status
April 28, 2026
Additional reason for stock ineligible for margin trading
April 15, 2026
Decision on stock removed out of trading restriction, trading suspension and Notice on stock status
February 11, 2026
Stock ineligible for margin trading
June 1, 2025
Research American Vietnamese Biotech, Inc.
American Vietnamese Biotech, Inc. investor report
Review AI stock analysis and investor report context for AMV:HNX.
American Vietnamese Biotech, Inc. company profile
View the public company page for American Vietnamese Biotech, Inc. on 6ix.
American Vietnamese Biotech, Inc. news
Read company news and market updates connected to American Vietnamese Biotech, Inc..
American Vietnamese Biotech, Inc. investor events
Find investor webinars, events, and replay context for American Vietnamese Biotech, Inc..